514 related articles for article (PubMed ID: 25559893)
1. Neutrophil-related factors as biomarkers in EAE and MS.
Rumble JM; Huber AK; Krishnamoorthy G; Srinivasan A; Giles DA; Zhang X; Wang L; Segal BM
J Exp Med; 2015 Jan; 212(1):23-35. PubMed ID: 25559893
[TBL] [Abstract][Full Text] [Related]
2. Induced CNS expression of CXCL1 augments neurologic disease in a murine model of multiple sclerosis via enhanced neutrophil recruitment.
Grist JJ; Marro BS; Skinner DD; Syage AR; Worne C; Doty DJ; Fujinami RS; Lane TE
Eur J Immunol; 2018 Jul; 48(7):1199-1210. PubMed ID: 29697856
[TBL] [Abstract][Full Text] [Related]
3. An IFNγ/CXCL2 regulatory pathway determines lesion localization during EAE.
Stoolman JS; Duncker PC; Huber AK; Giles DA; Washnock-Schmid JM; Soulika AM; Segal BM
J Neuroinflammation; 2018 Jul; 15(1):208. PubMed ID: 30012158
[TBL] [Abstract][Full Text] [Related]
4. Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils.
Eberle M; Ebel P; Mayer CA; Barthelmes J; Tafferner N; Ferreiros N; Ulshöfer T; Henke M; Foerch C; de Bazo AM; Grösch S; Geisslinger G; Willecke K; Schiffmann S
Immunol Cell Biol; 2015 Oct; 93(9):825-36. PubMed ID: 25833068
[TBL] [Abstract][Full Text] [Related]
5. GM-CSF Promotes Chronic Disability in Experimental Autoimmune Encephalomyelitis by Altering the Composition of Central Nervous System-Infiltrating Cells, but Is Dispensable for Disease Induction.
Duncker PC; Stoolman JS; Huber AK; Segal BM
J Immunol; 2018 Feb; 200(3):966-973. PubMed ID: 29288202
[TBL] [Abstract][Full Text] [Related]
6. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
Mony JT; Khorooshi R; Owens T
Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
[TBL] [Abstract][Full Text] [Related]
7. Lack of ceramide synthase 2 suppresses the development of experimental autoimmune encephalomyelitis by impairing the migratory capacity of neutrophils.
Barthelmes J; de Bazo AM; Pewzner-Jung Y; Schmitz K; Mayer CA; Foerch C; Eberle M; Tafferner N; Ferreirós N; Henke M; Geisslinger G; Futerman AH; Grösch S; Schiffmann S
Brain Behav Immun; 2015 May; 46():280-92. PubMed ID: 25697397
[TBL] [Abstract][Full Text] [Related]
8. Sickness behaviour is induced by a peripheral CXC-chemokine also expressed in multiple sclerosis and EAE.
Campbell SJ; Meier U; Mardiguian S; Jiang Y; Littleton ET; Bristow A; Relton J; Connor TJ; Anthony DC
Brain Behav Immun; 2010 Jul; 24(5):738-46. PubMed ID: 20138139
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of Socs3 leads to brain-targeted EAE via enhanced neutrophil activation and ROS production.
Yan Z; Yang W; Parkitny L; Gibson SA; Lee KS; Collins F; Deshane JS; Cheng W; Weinmann AS; Wei H; Qin H; Benveniste EN
JCI Insight; 2019 Apr; 5(9):. PubMed ID: 30939124
[TBL] [Abstract][Full Text] [Related]
10. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
11. Meningeal mast cell-T cell crosstalk regulates T cell encephalitogenicity.
Russi AE; Walker-Caulfield ME; Guo Y; Lucchinetti CF; Brown MA
J Autoimmun; 2016 Sep; 73():100-10. PubMed ID: 27396526
[TBL] [Abstract][Full Text] [Related]
12. CD30 ligand is a new therapeutic target for central nervous system autoimmunity.
Shinoda K; Sun X; Oyamada A; Yamada H; Muta H; Podack ER; Kira J; Yoshikai Y
J Autoimmun; 2015 Feb; 57():14-23. PubMed ID: 25533628
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis.
Bozoyan L; Dumas A; Patenaude A; Vallières L
J Neuroinflammation; 2015 Sep; 12():173. PubMed ID: 26377915
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of the G protein Gαq ameliorates experimental autoimmune encephalomyelitis with impaired DC-derived IL-6 production and Th17 differentiation.
Lai W; Cai Y; Zhou J; Chen S; Qin C; Yang C; Liu J; Xie X; Du C
Cell Mol Immunol; 2017 Jun; 14(6):557-567. PubMed ID: 28216651
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin gene-related peptide enhances experimental autoimmune encephalomyelitis by promoting Th17-cell functions.
Mikami N; Watanabe K; Hashimoto N; Miyagi Y; Sueda K; Fukada S; Yamamoto H; Tsujikawa K
Int Immunol; 2012 Nov; 24(11):681-91. PubMed ID: 22843730
[TBL] [Abstract][Full Text] [Related]
16. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-1, a cell surface proteoglycan, negatively regulates initial leukocyte recruitment to the brain across the choroid plexus in murine experimental autoimmune encephalomyelitis.
Zhang X; Wu C; Song J; Götte M; Sorokin L
J Immunol; 2013 Nov; 191(9):4551-61. PubMed ID: 24078687
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.
Ulges A; Witsch EJ; Pramanik G; Klein M; Birkner K; Bühler U; Wasser B; Luessi F; Stergiou N; Dietzen S; Brühl TJ; Bohn T; Bündgen G; Kunz H; Waisman A; Schild H; Schmitt E; Zipp F; Bopp T
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10145-50. PubMed ID: 27555590
[TBL] [Abstract][Full Text] [Related]
19. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
[TBL] [Abstract][Full Text] [Related]
20. Chloroquine-treated dendritic cells require STAT1 signaling for their tolerogenic activity.
Thome R; Bonfanti AP; Rasouli J; Mari ER; Zhang GX; Rostami A; Verinaud L
Eur J Immunol; 2018 Jul; 48(7):1228-1234. PubMed ID: 29572810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
